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Hyperpolarization produces nuclear spin polarization that is several orders of magnitude larger than that
achieved at thermal equilibrium thus providing extraordinary contrast and sensitivity. As a parahydrogen
induced polarization (PHIP) technique that does not require chemical modiﬁcation of the substrate to
polarize, Signal Ampliﬁcation by Reversible Exchange (SABRE) has attracted a lot of attention. Using a
prototype parahydrogen polarizer, we polarize two drugs used in the treatment of tuberculosis, namely
pyrazinamide and isoniazid. We examine this approach in four solvents, methanol-d4, methanol, ethanol
and DMSO and optimize the polarization transfer magnetic ﬁeld strength, the temperature as well as
intensity and duration of hydrogen bubbling to achieve the best overall signal enhancement and hence
hyperpolarization level.
 2013 Elsevier Inc. Open access under CC BY license.1. Introduction nal enhancements have been observed in a variety of situationsBy producing nuclear spin polarization far beyond that available
at thermal equilibrium, hyperpolarization can provide improved
sensitivity for NMR, enabling the detection of less concentrated
molecules. In the area of molecular imaging, MRI has recently been
used to study the distribution [1] and metabolism [2–4] of hyper-
polarized substrates. For instance, multiple studies have reported
on the conversion of hyperpolarized 13C-labeled pyruvate to its
metabolic products, alanine, lactate and carbonate in vivo [2–6],
in which higher lactate production is an important indicator of
cancer. This technique is already being translated to the clinic
and a ﬁrst trial is ongoing [7].
Major hyperpolarization techniques include dynamic nuclear
polarization (DNP) [8,9], spin exchange optical pumping polariza-
tion of noble gases [10] and parahydrogen induced polarization
(PHIP) [11–16]. Parahydrogen is a spin isomer of hydrogen with
an antisymmetric singlet spin state. By incorporating this pure spin
state into a molecule through a hydrogenation reaction, large sig-as ﬁrst conceived by Bowers and Weitekamp [12] and Pravica
andWeitekamp [14]. In 2009, Duckett’s group developed a parahy-
drogen polarization technique that works without the need for the
chemical modiﬁcation of the substrate [17]. In this approach, the
substrate and the parahydrogen bind to a catalyzing metal com-
plex simultaneously, thus enabling polarization to be transferred
to the substrate through the scalar coupling network. The polarized
substrate is subsequently released, and replaced by new substrate
which is polarized in turn. Such Signal Ampliﬁcation By Reversible
Exchange (SABRE) has already been applied to detect trace
amounts of chemicals [18–20] and used in conjunction with
zero-ﬁeld NMR spectroscopy [21].
According to a theoretical description of SABRE, the signal
enhancement level depends on the binding kinetics and the mag-
netic ﬁeld in which polarization transfer occurs [22]. In order to
achieve better enhancement, new catalyst precursors have been
developed to tune the binding kinetics. Enhancements can be
boosted by using the bulky electron-donating phosphines of the
Crabtree catalyst [23]. Currently, an iridium N-heterocyclic carbene
complex [24] shows the highest polarization transfer efﬁciency.
In this paper, we investigated the SABRE polarization of two
drugs that are used clinically, isoniazid and pyrazinamide [25]. Iso-
niazid treats tuberculosis meningitis, and pyrazinamide is used in
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tuberculosis. Isoniazid is a pyridine derivative, and pyrazinamide is
a pyrazine derivative. They are nitrogen containing heterocyclic
aromatic organic compounds (Fig. 1) and are thus able to bind to
the iridium atom of the catalyst precursor. Therefore, they are suit-
able for SABRE polarization.
In previous work, methanol-d4 was used as a solvent for SABRE
polarization, which is not suitable for injection into small animals.
In this paper, we therefore also investigated the possibility of SA-
BRE polarization in solvents more suitable for in vivo applications,
namely DMSO and ethanol.
The enhancement efﬁciency depends on the polarizing mag-
netic ﬁeld and temperature as well as on the hydrogen bubbling
intensity and time. These conditions were optimized for each
solvent.2. Experimental section
2.1. Sample preparation
The samples used for the SABRE experiments contained
0.40 mM of the catalyst precursor [Ir(COD)(IMes)Cl] [COD = cyclo-
octadiene, IMes = 1,3-bis(2,4,6-trimethylphenyl)imidazole-2-yli-
dene] and 4.0 mM of the selected substrate, either isoniazid or
pyrazinamide (Sigma–Aldrich, St. Louis, MO). This catalyst to sub-
strate ratio of 1:10 was chosen following Ref. [26]. The solvents
were methanol-d4 (Cambridge Isotope Laboratories, Andover,
MA), methanol, ethanol and dimethyl sulfoxide (DMSO) (Sigma–
Aldrich, St. Louis, MO). The total sample volume was 3.5 mL.2.2. SABRE polarization
Parahydrogen was prepared using a parahydrogen generator
that cools the hydrogen gas to 36 K in the presence of a metal cat-
alyst, after which the fraction of parahydrogen becomes 92.5%.
Subsequently, the sample containing the substrate and the catalyst
precursor was loaded into a mixing chamber positioned under-
neath the magnet of a Bruker 700 MHz spectrometer. The temper-
ature of the sample was controlled by a home-built water bath
system. Polarization was achieved by bubbling parahydrogen
through the sample. The sample was then pneumatically trans-
ferred to the ﬂow cell in the spectrometer. This process took about
2 s. Once the sample was in the NMR probe, spectra were acquired
immediately. After data acquisition, the sample was returned to
the mixing chamber for repolarization.2.3. NMR measurement
In experiments using methanol-d4 as a solvent, NMR spectra
were acquired after a p/2 hard pulse. When non-deuterated sol-
vents were used, solvent suppression was achieved using excita-
tion sculpting pulse sequences [27]. The shaped pulses were
20 ms Gaussian pulses that excite all of the solvent peaks.Fig. 1. Chemical structure of isoniazid and pyrazinamide.3. Results
3.1. Pyrazinamide
The total magnetic ﬁeld of the sample in the preparation cham-
ber is the vector summation of the stray ﬁeld of the scanner mag-
net and the magnetic ﬁeld generated by a small electromagnetic
coil surrounding the sample, which is tunable up to ±145 G. The
mixing chamber is placed directly underneath the NMR magnet
in a region where the stray ﬁeld is vertical so that it can be com-
pletely compensated to achieve a zero overall magnetic ﬁeld in
the sample. According to the SABRE mechanism, optimum
enhancement occurs when the differences in resonance frequency
of the protons are of the same order as the scalar couplings [22].
While the optimal polarization ﬁeld cannot be predicted straight-
forwardly, it can be easily determined experimentally by varying
the magnetic ﬁeld with the small coil around the sample. Fig. 2
shows the dependence of the enhancement of pyrazinamide on lo-
cal magnetic ﬁeld strength in methanol-d4 at room temperature.
In the range of 0–120 G, the signal enhancement for all the
three aromatic protons of pyrazinamide was always of the same
order of magnitude and negative. The shape of the dependency
of the enhancement was a ‘‘V’’ curve with a maximum absolute
enhancement at 65 G, which is very close to the value 70 G re-
ported by Cowley et al. for pyridine [24].
Subsequently, the parameters for the hydrogen bubbling were
tested at the optimal magnetic ﬁeld of 65 G. The mixing of hydro-
gen gas with the catalyst precursor and substrate in liquid phase,
which is required by the SABRE mechanism, was achieved by bub-
bling the hydrogen gas through a porous ceramic rod. This bub-
bling was controlled by the input and output pressure of
parahydrogen in the mixing chamber. Usually, a larger pressure
difference meant more intense bubbling. However, a very large
bubble size produced by a pressure difference that is too large
should be avoided. The hydrogen bubbling time should be long en-
ough to ensure complete reaction of hydrogen, substrates and the
catalyst. In our case, we increased the hydrogen bubbling time un-
til the polarization stopped increasing. These timing and pressure
parameters were solvent dependent (Table 1).
The temperature dependency was also investigated. For the
polarization of pyrazinamide in methanol-d4 in a magnetic ﬁeld
of 65 G, the enhancements (Fig. 3) of all three protons were rela-
tively low for temperatures below 20.0 C. From 20.0 to 46.1 C,
the enhancements of all three protons increased dramatically, be-
fore leveling off.
Methanol-d4 was chosen as the ﬁrst test solvent based on the
literature [17,20,23,24]. Methanol was also investigated and found
to give enhancements only slightly lower than its deuterated ana-
log (Fig. 4). Two other solvents, ethanol and DMSO, were chosenFig. 2. Enhancement of pyrazinamide protons as a function of polarization
magnetic ﬁeld strength in methanol-d4 at room temperature.
Table 1
Parahydrogen bubbling parameters for the four solvents used in the paper.
Solvent Forward
pressure
(bar)
Backward
pressure
(bar)
Bubbling
time (s)
Methanol-d4 2.5 1.0 30
Methanol 2.5 1.0 10
Ethanol 2.0 0.0 10
DMSO 4.9 0.0 50
Fig. 3. Enhancement levels for pyrazinamide 1H NMR signals in methanol-d4
revealing a dependence on polarization temperature for transfer in a magnetic ﬁeld
of 65 G.
Fig. 4. Polarization transfer ﬁeld dependence of the observed 1H signal enhance-
ment of pyrazinamide in (a) methanol, (b) ethanol and (c) DMSO at room
temperature.
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injection for study in vivo. DMSO is often used as a drug vehicle
in medical research. Water was not considered as a solvent due
to the catalyst precursor being insoluble. The polarization ﬁeld
dependencies for pyrazinamide in these other solvents showed
patterns similar to methanol-d4, with optimal enhancement at
65 G. While the enhancement in ethanol resembled that in metha-
nol, it was about an order of magnitude smaller in DMSO (Fig. 4).
The enhancement dependencies on temperature in these three
solvents at 65 G are plotted in Fig. 5. The polarization studies in
DMSO were only carried out at higher temperatures because it
was difﬁcult to transfer the sample when it is too viscous, which
occurs at a temperature close to the freezing point of the solvent
(DMSO, 19 C).
Compared to methanol-d4, the enhancements in methanol were
reduced to a half and in ethanol to a quarter, while those in DMSO
were an order of magnitude smaller and thus less suitable to polar-
ize pyrazinamide.3.2. Isoniazid
In the case of isoniazid, the enhancements of the two protons
again showed a ‘‘V-curve’’ dependency on polarization magnetic
ﬁeld (Fig. 6). Interestingly, at 0 G, the polarization of proton 2
was negative while that of proton 3 was positive. The optimal mag-
netic ﬁeld for both protons was again very similar, namely around
60–65 G. A magnetic ﬁeld of 65 G was therefore again chosen to
study the temperature dependence. At this ﬁeld strength, the
polarization of protons was almost twice of that of proton 3, prob-
ably due to proton 2 being closer to the nitrogen atom, which di-
rectly bonds to iridium upon ligation.
The polarization of isoniazid in methanol-d4 at a magnetic ﬁeld
of 65 G was measured over the temperature range 4.7–54.4 C
(Fig. 7). The signal enhancements observed for both protons in-
creased with temperature until reaching a maximum enhance-
ments of 220 and 150 fold at 46.1 C. At higher temperature
(54.4 C), the enhancements were slightly decreased.The polarization of isoniazid in the other three solvents was
also investigated for a polarization transfer magnetic ﬁeld of 65 G
(Fig. 9), even though this magnetic ﬁeld was not optimal for the
polarization in ethanol at room temperature (Fig. 8). The best
enhancements were always at 46.1 C. The SABRE enhancement
of isoniazid shows similar solvents dependence as that of pyrazin-
amide. Compared to methanol-d4, the enhancements in methanol
were slightly lower, in ethanol about a half, and in DMSO about
one ﬁfth, making it a less suitable solvent in which to polarize iso-
niazid via SABRE.4. Discussion
According to SABRE theory [22], polarization transfer, binding
kinetics and spin relaxation determine the size of the enhance-
ment. The polarization of parahydrogen is transferred to the sub-
strate through J coupling networks, the strength of which is
determined by the chemical structure and bonding strength of
the substrate-metal complex. Since the multi-bond J couplings be-
tween the parahydrogen and the substrate are small, a relative
Fig. 5. Dependence of the signal enhancement of pyrazinamide on polarization
temperature in methanol (a), ethanol (b) and DMSO (c) in a magnetic ﬁeld of 65 G.
Notice the different vertical scales.
Fig. 6. Dependence of enhancement of isoniazid in methanol-d4 on polarization
magnetic ﬁeld strength at room temperature.
Fig. 7. Dependence of the signal enhancement observed for isoniazid in methanol-
d4 on polarization temperature in a magnetic ﬁeld of 65 G.
Fig. 8. Polarization transfer ﬁeld dependence for the 1H signal enhancement of
isoniazid in (a) methanol, (b) ethanol at room temperature, and (c) DMSO at 37.5 C.
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quired for effective transfer. Thus, in the case of fast binding kinet-
ics, the short lifetime of the substrate-metal complex will decreaseSABRE enhancements. On the other hand, since the concentration
of the substrate is much larger than that of the catalyst precursor,
polarization of all of the substrate molecules requires relative fast
exchange between the substrate in free form and metal bound
form. During the exchange, the spin relaxation decreases the
Fig. 9. 1H NMR signal enhancement of pyrazinamide in methanol (a), ethanol (b)
and DMSO (c) dependence on polarization temperature in a magnetic ﬁeld of 65 G.
Notice the different vertical scales.
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lead to signiﬁcant SABRE enhancements either.
These data show a general trend that the enhancements are bet-
ter at higher temperature than at room temperature. Generally, the
binding kinetics and molecular tumbling are faster at higher tem-
perature. Also, the spin relaxation rates are smaller at higher tem-
perature for these small molecules in the extreme narrowing limit.
Faster binding kinetics and slower relaxation lead to higher
enhancements, with the best enhancement in most cases occurring
at 37.5–46.1 C.
The enhancements are negatively correlated with the viscosity
of the solvents (methanol < ethanol < DMSO). In the extreme
narrowing limit, proton spin relaxation rates are faster for the
substrate-metal complex in more viscous solvents, causing
polarization loss and a concomitant lower SABRE enhancement.
By replacing the protons with deuterons, the spin relaxation re-
duces and methanol-d4 showed the best enhancement.In pyrazinamide the parahydrogen spin order is shared with
three protons, while it is shared with four in isoniazid. One might
therefore expect that for equivalent transfer efﬁciency the levels of
signal enhancement would be 4:3. Given the 1400:230 ratio, we
conclude that pyrazinamide reﬂects a better spin system. SABRE
enhancement requires the complexation of the substrate of the
catalyst precursor, which is through the formation of a chemical
bond between the iridium and the nitrogen in the aromatic ring.
Effective polarization transfer requires strong J coupling. In the
substrate metal complex, the polarization can be transferred to
proton 2 in isoniazid and all three aromatic proton in pyrazinamide
through a 4-bond J coupling. However, the transfer to proton 3 in
isoniazid is through a much smaller 5-bond J coupling. This is
the probable cause of the much smaller enhancement of proton 3
compared to that of proton 2 in isoniazid. In addition, pyrazina-
mide has two nitrogen atoms in the aromatic ring, both of which
are able to bind to iridium. This is one possible reason that the
enhancement for pyrazinamide is much higher than that of
isoniazid.
5. Conclusion
We report the polarization of two drugs via SABRE that are used
clinically for treating tuberculosis, pyrazinamide and isoniazid [25].
To achieve the best enhancement level, the strength of the polariz-
ing magnetic ﬁeld and temperature were optimized together with
the bubbling of parahydrogen. Using a ﬁxed catalyst-to-substrate
ratio of 1:10, the best enhancements for all three protons in
pyrazinamide were obtained in a polarizing magnetic ﬁeld of 65 G
for all solvents. In all solvents, the enhancements at higher temper-
ature were better than that at room temperature. In methanol-d4,
up to 1400 times enhancement was obtained, corresponding to
8% polarization, which is comparable to that of DNP [28–30]. In
methanol, ethanol and DMSO, the best enhancements were 960,
320 and 40 respectively. For isoniazid, the best enhancements
in methanol-d4, methanol, ethanol and DMSO were 230, 140,
120 and 34 respectively in a magnetic ﬁeld of 65 G. The
enhancement of proton 3 was only 50–70% of that of proton 2.
Both systems show a similar temperature proﬁle where
37.5–46.1 C seems to reﬂect the optimum temperature and hence
lifetime of the polarization transfer catalyst. It would therefore
appear that the J-coupling framework in the pyrazinamide system
is more suited for optimal transfer. Considering the solvent effects,
the SABRE enhancement can be increased by minimizing the spin
relaxation of the substrate-metal complex, namely using less vis-
cous solvent and deuterated solvent.
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